title: Amiodarone-induced thrombosis:  a case series and brief review of the literature.
abstract: Amiodarone is used extensively in clinical practice for the treatment of arrhythmias but is associated with a number of well-known side effects. We present 3 cases of extensive thrombosis occurring secondary to intravenous amiodarone. In cases like these, amiodarone must be stopped immediately and patients started on appropriate anticoagulation therapy. Providing education to nursing and pharmacy staff regarding the administration of IV amiodarone and the necessity of defining institutional guidelines are central to decreasing the risk of complications from using this widely available antiarrhythmic agent.
authors.affiliation: Department of Cardiology, University of Alabama Birmingham, Birmingham, AL 35294-0006, USA. figbal@uab.edu
authors.forename: Fahad M
authors.initials: FM
authors.lastname: Iqbal
authors.forename: Bobby
authors.initials: B
authors.lastname: Chawla
authors.forename: Jayanth
authors.initials: J
authors.lastname: Koneru
authors.forename: Mahesh
authors.initials: M
authors.lastname: Bikkina
mesh_terms: D000368:Aged; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000925:Anticoagulants / Q000627:therapeutic use; D004509:Education, Nursing, Continuing / Q000379:methods; D004513:Education, Pharmacy, Continuing / Q000379:methods; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D013927:Thrombosis / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D000638:Amiodarone